Modus Therapeutics AB
556669-2199ActiveSwedish biotech developing sevuparin for severe inflammatory diseases.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2004
- Grundat
Nyckelbeslutsfattare
John Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
+3 fler kontakter i Funnelfeedr
Beskrivning
Modus Therapeutics is a Swedish biotechnology company focused on developing novel treatments for severe medical conditions with high unmet needs. Their proprietary polysaccharide, sevuparin, is the core asset under development. Sevuparin is designed as a heparinoid that modifies inflammation while m...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556669219901
Beslutsfattare
7 kontakter i FunnelfeedrJohn Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
Ellen Donnelly
Board Member
Claes Lindblad
CFO & Head of IR
Ellen K. Donnelly
Board Member
Liknande företag
20 liknande företag i FunnelfeedrSangair AB
3 anställdaDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
ZEALAND PHARMA A/S
0 anställdaDeveloping peptide medicines for metabolic health challenges globally.
Disruptive Pharma AB (publ)
5–9 anställdaSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
Abera Bioscience AB
Developing next-generation nasal vaccines using modular OMV platform technology.
bioMérieux Sweden AB
20–49 anställdaWorld leader developing in vitro diagnostics for health and safety.
Utforska mer
Frågor om Modus Therapeutics AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo